Charlotte Hyldgaard Selected Research

Inflammation (Inflammations)

1/2022

Intravenous immunoglobulin treatment stabilizing a patient with Anti-PL7 antisynthetase syndrome with interstitial lung disease and eosinophilic inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charlotte Hyldgaard Research Topics

Disease

4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2019
2	Antisynthetase syndrome 01/2022 - 01/2019
2	Idiopathic Pulmonary Fibrosis 10/2021 - 01/2014
1	Fatigue 04/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pulmonary Hypertension 10/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2021
1	Disease Progression 10/2021
1	Rheumatoid Arthritis 01/2019
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2017
1	Pneumonia (Pneumonitis) 01/2014
1	Tuberculosis (Tuberculoses) 03/2011

Drug/Important Bio-Agent (IBA)

2	pirfenidoneIBA 10/2021 - 01/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 04/2022
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 10/2021
1	nintedanibIBA 10/2021
1	AntigensIBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 03/2011

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2019